3,881
edits
Changes
HAEM5:Volunteer Assignments and Opportunities (view source)
Revision as of 20:21, 17 December 2023
, 20:21, 17 December 2023no edit summary
|-
|-
!Disease (5th Edition)!!Page Type!!Author (5th Edition)!!Date Assigned to Author (5th Edition)!!Target Completion Date (5th Edition)!!Content Status (5th Edition)(Pending or Complete)!!Date Completed by Author (5th Edition)!!Associate Editor!!Date of Last Editor Review!!Notes (5th Edition)
!Disease (5th Edition)!!Page Type!!Author (5th Edition)!!Date Assigned to Author (5th Edition)!!Target Completion Date (5th Edition)!!Content Status (5th Edition)(Pending or Complete)!!Date Completed by Author (5th Edition)!!Associate Editor!!Date of Last Editor Review!!Notes (5th Edition)
!Correlated Prior Disease Name (4th Edition)
!Correlated Prior Disease Name (4th Edition)
!Correlated Prior Author (4th Edition)
!Correlated Prior Author (4th Edition)
!Notes (4th Edition)
|-
|-
|CHAPTER 2 (MYELOID PROLIFERATIONS AND NEOPLASMS)
|CHAPTER 2 (MYELOID PROLIFERATIONS AND NEOPLASMS)
|-
|-
|Clonal haematopoiesis||Disease|| || || || || ||Fabiola Quintero-Rivera (FQR)|| ||
|Clonal haematopoiesis||Disease|| || || || || ||Fabiola Quintero-Rivera (FQR)|| ||
|NEW
|NEW
|NEW
|NEW
|
|-
|-
|Clonal cytopenias of undetermined significance||Disease|| || || || || ||FQR|| ||
|Clonal cytopenias of undetermined significance||Disease|| || || || || ||FQR|| ||
|NEW
|NEW
|NEW
|NEW
|
|-
|-
|Chronic myeloid leukaemia||Disease|| || || || || ||FQR|| ||
|Chronic myeloid leukaemia||Disease|| || || || || ||FQR|| ||
|Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive
|Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive
|Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine)
|Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine)
|
|-
|-
|Chronic neutrophilic leukaemia||Disease|| || || || || ||FQR|| ||
|Chronic neutrophilic leukaemia||Disease|| || || || || ||FQR|| ||
|Chronic Neutrophilic Leukemia (CNL)
|Chronic Neutrophilic Leukemia (CNL)
|Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine <nowiki>**</nowiki>contributed equally
|Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine <nowiki>**</nowiki>contributed equally
|
|-
|-
|Chronic eosinophilic leukaemia||Disease|| || || || || ||FQR|| ||
|Chronic eosinophilic leukaemia||Disease|| || || || || ||FQR|| ||
|Chronic Eosinophilic Leukemia, Not Otherwise Specified
|Chronic Eosinophilic Leukemia, Not Otherwise Specified
|Chelsea D. Kramish; Daynna J.Wolff
|Chelsea D. Kramish; Daynna J.Wolff
|
|-
|-
|Polycythaemia vera||Disease|| || || || || ||FQR|| ||
|Polycythaemia vera||Disease|| || || || || ||FQR|| ||
|Polycythemia Vera (PV)
|Polycythemia Vera (PV)
|Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center
|Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center
|
|-
|-
|Essential thrombocythaemia||Disease||Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN|| || || || ||FQR|| ||
|Essential thrombocythaemia||Disease||Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN|| || || || ||FQR|| ||
|Essential Thrombocythemia (ET)
|
|
|
|
|-
|-